Lantern PharmaLTRN
13F holders, Q1 2026 (March 31)33holders
2new positions
3sold out
1famous investor
$1.37avg. 13F price*
At the end of Q1 2026, 33 institutions reported holding Lantern Pharma Inc. (LTRN) in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 3 sold out. The largest holders were BIOS Capital Management, LP ($1.2M), Vanguard Capital Management LLC ($455K) and CM Management, LLC ($343K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lantern Pharma Inc.
- CUSIP
- 51654W101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $747 |
| Exits | 3 | $187K |
All 13F filers, Q4 2025 → Q1 2026: 63,975 shares bought and 232,202 shares sold, net −168,227 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| BIOS Capital Management, LP | 2.24% | Reduce -14.4% | 864,435 | $1.2M |
| Vanguard Capital Management LLC | 0.00% | — | 332,079 | $455K |
| CM Management, LLC | 0.29% | Add +11.1% | 250,000 | $343K |
| Renaissance Technologies | 0.00% | Add +5.1% | 116,000 | $159K |
| Geode Capital Management, LLC | 0.00% | Add +15.4% | 111,646 | $153K |
| Westside Investment Management, Inc. | 0.01% | Add +39.4% | 50,050 | $69K |
| Voss Capital, LP | 0.00% | No change | 50,000 | $69K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 49,607 | $68K |
| BlackRock, Inc. | 0.00% | Add +2.3% | 45,267 | $62K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -2.7% | 38,060 | $52K |
| NewEdge Advisors, LLC | 0.00% | Reduce -28.0% | 27,399 | $38K |
| Horizon Kinetics Asset Management LLC | 0.00% | Reduce -4.4% | 26,373 | $36K |
| DAVENPORT & Co LLC | 0.00% | No change | 23,814 | $33K |
| State Street Corp. | 0.00% | No change | 23,652 | $32K |
| Bank of New York Mellon Corp | 0.00% | Reduce -19.6% | 21,301 | $29K |
| Northern Trust Corp. | 0.00% | No change | 15,589 | $21K |
| Focus Partners Wealth | 0.00% | Reduce -3.4% | 15,432 | $21K |
| Cetera Investment Advisers | 0.00% | No change | 12,228 | $17K |
| UBS Group AG | 0.00% | Reduce -5.2% | 10,077 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +324.4% | 3,569 | $5K |
| Vanguard Global Advisers, LLC | 0.00% | — | 2,355 | $3K |
| SBI Securities Co., Ltd. | 0.00% | Add +0.1% | 2,144 | $3K |
| Curio Wealth, LLC | 0.00% | No change | 2,000 | $3K |
| Wells Fargo & Company | 0.00% | No change | 1,475 | $2K |
| Morgan Stanley | 0.00% | No change | 601 | $823 |
| FMR LLC | 0.00% | New | 500 | $685 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 500 | $685 |
| Osaic Holdings, Inc. | 0.00% | Add +2.3% | 220 | $301 |
| Simplex Trading, LLC | 0.00% | Reduce -95.3% | 107 | $146 |
| JPMorgan Chase & Co. | 0.00% | Add +40.6% | 97 | $120 |
| Citigroup Inc. | 0.00% | New | 45 | $62 |
| Group One Trading LLC | 0.00% | Reduce -99.4% | 23 | $32 |
| Key Financial Inc | 0.00% | No change | 2 | $3 |
"% of holder's portfolio" is LTRN's weight in each manager's 13F, not the share of Lantern Pharma Inc. the manager owns.